Escape velocity out of a small base: management describes the business compounding at a rate its own size cannot absorb
The model's full reasoning — Q1 2022 call → NOWe need to determine if management describes the company as being at a point where the rate of accumulation is the dominant fact, with both conditions: (1) management itself reaches for multiples when describing what is happening now, and (2) management treats the company as still small against what it is already doing. Let's examine the transcript. Tony Hunt's opening remarks: "we delivered an outstanding first quarter for the company, with revenues topping $200 million for the first time, along with excellent gross margins and operating margins. The story in the quarter was the continued strength in our base business, which was up 37% year-over-year and up 20% sequentially versus the fourth quarter of 2021. We saw robust growth in our core monoclonal antibody markets, an increasing contribution from gene therapy accounts. Gene therapy growth was up over 100% and each of our franchises delivered over 30% year-over-year revenue growth, except for proteins which came in flat as expected." He mentions gene therapy growth up over 100%, but that's a percentage, not a multiple. He says "up over 100%" which is a doubling, but is that a recurring framing? He also says "each of our franchises delivered over 30% year-over-year revenue growth" - that's incremental, not multiples. Later: "From an orders perspective, we finished the quarter with a book-to-bill ratio of 1, which is encouraging given the COVID orders contributed only 15% of our overall order book. This highlights the real strength of our base business. Our first quarter orders increased 20% year-over-year and over 17% sequentially versus the fourth quarter of last year." That's incremental. He mentions "Gene therapy growth was up over 100%" - that's a multiple, but is it a recurring theme? He also says "cell and gene therapy, where we saw a record quarterly revenue that accounted for 14% of our total revenue in the first quarter. This exceptional performance, led by our Filtration business, represented growth of more than 100% year-on-year." So again, more than 100% growth. But is management framing the entire business as "several times what we were"? They talk about base business up 37%, gene therapy up over 100%, but that's not necessarily "multiples" in the sense of "doubled, tripled, several times over". They use percentages like 100% which is a doubling, but they don't say "doubled" explicitly.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| SNOW | Snowflake Inc. | Q3 2022 | 2021-12-01 | A |
SNOW · Q3 2022 → YESThe question is about whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as st...YES Frank Slootman repeatedly frames the current state in terms of multiples of the recent past: product revenue “growing 110% year-on-year” (more than doubling), EMEA “up 174%” and Asia-Pacific “219%”, BUILD Summit registrations “three times last year’s”, Snow Day “ 23,000 registrations”, Data Marketplace “grew 41%”, stable edges “more than 130% annual increase”, Powered By Snowflake partners “growing 137% quarter-on-quarter” and product revenue from them “173% year-on-year”.
DASH · Q3 2023 → YESThe question is whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as still sm...YES The transcript shows management repeatedly framing the business in terms of multiples of its recent past: non-restaurant selection "going from 0 nearly 3 years ago to a multibillion-dollar business that's at scale now growing fast"; grocery GOV "has doubled year-on-year"; international growth "at multiples of what we see around the world"; and new verticals accelerating from the prior quarter.
SYM · Q3 2022 → YESThe question is about whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as st...YES Management repeatedly frames the current state using multiples of recent past activity: backlog more than doubled (from $5.2B to $11.